STAGE IIIA BREAST CANCER

This large study tested whether temporarily shutting down the ovaries and adding different hormone-blocking drugs could better prevent breast cancer from returning compared to standard treatment alone. It involved over 3,000 premenopausal women who had surgery for hormone-sensiti…

This study tested a two-drug combination (fulvestrant and palbociclib) to control breast cancer in patients aged 70 and older who could not undergo surgery due to frailty or who refused it. The goal was to see if this non-surgical approach could keep the cancer from growing for a…

This study tested whether adding the hormone therapy fulvestrant to a new drug called alisertib works better than alisertib alone for women with advanced breast cancer that has spread and stopped responding to standard hormone treatments. It involved 96 postmenopausal women. Rese…

This small, early study tested whether short-term use of anti-inflammatory drugs—fish oil capsules or the medication celecoxib—could change the biology of breast cancer diagnosed around pregnancy. Researchers gave one of these treatments to 42 young women for 1-3 weeks before the…